Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat

• Main Authors: M Teixeira (Author), P Rodrigues-Santos (Author), P Garrido (Author), E Costa (Author), B Parada (Author), J Sereno (Author), R Alves (Author), L Belo (Author), F Teixeira (Author), A Santos-Silva (Author), F Reis (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2012-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Recombinant human erythropoietin (rhEPO) therapy under circumstances of moderate chronic renal failure (CRF), with yet lower kidney and heart lesion, may have a protective cardiac effect beyond the correction of anemia, whose mechanism deserves better elucidation, namely by clarifying the...